320045749	320045749	CD	B-NP	O
|	|	NN	I-NP	O
SMH	SMH	NN	I-NP	O
|	|	NN	I-NP	O
29997897	29997897	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8850939	8850939	CD	B-NP	O
|	|	CC	I-NP	O
5/24/2007	5/24/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
musculoskeletal	musculoskeletal	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/16/2007	10/16/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/30/2007	4/30/2007	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
RASHDI	RASHDI	NNP	B-NP	O
,	,	,	O	O
CHRISTOPHER	CHRISTOPHER	NNP	B-NP	O
223-91-47-1	223-91-47-1	CD	I-NP	O
A	A	NNP	I-NP	O
Ment	Ment	NNP	I-NP	O
Scot	Scot	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
6/6/07	6/6/07	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
VIXAYACK	VIXAYACK	NNP	B-NP	O
,	,	,	O	O
EMILIO	EMILIO	NNP	B-NP	O
JON	JON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NNP	B-NP	O
MEDICATIONS	MEDICATIONS	NNP	I-NP	O
ON	ON	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

ASPIRIN	ASPIRIN	NNP	B-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	VBD	B-VP	O
325	325	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

FUROSEMIDE	FUROSEMIDE	NN	B-NP	B-protein
60	60	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

METOPROLOL	METOPROLOL	NNP	B-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	B-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

SIMVASTATIN	SIMVASTATIN	NN	B-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	B-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

WARFARIN	WARFARIN	NN	B-NP	O
SODIUM	SODIUM	NN	I-NP	O
6	6	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QPM	QPM	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	I-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/28/07	7/28/07	CD	B-NP	O
by	by	IN	B-PP	O
FEGUEROA	FEGUEROA	NNP	B-NP	O
,	,	,	O	O
CAREY	CAREY	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
057079355	057079355	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/28/07	10/28/07	CD	B-NP	O
by	by	IN	B-PP	O
WADEMAN	WADEMAN	NNP	B-NP	O
,	,	,	O	O
OSVALDO	OSVALDO	NNP	B-NP	O
H.	H.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
209100063	209100063	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
IBUPROFEN	IBUPROFEN	NN	I-NP	O
400	400	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q8H	Q8H	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	O
LISINOPRIL	LISINOPRIL	NN	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/6/07	6/6/07	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ok	ok	VB	B-VP	O
METOPROLOL	METOPROLOL	NNP	B-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

SIMVASTATIN	SIMVASTATIN	NN	B-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/28/07	7/28/07	CD	B-NP	O
by	by	IN	B-PP	O
BALETTE	BALETTE	NNP	B-NP	O
,	,	,	O	O
MCKINLEY	MCKINLEY	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
057079355	057079355	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/28/07	10/28/07	CD	B-NP	O
by	by	IN	B-PP	O
HOA	HOA	NNP	B-NP	O
,	,	,	O	O
FREDRICK	FREDRICK	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
209100063	209100063	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
COUMADIN	COUMADIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
3.5	3.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
NOW	NOW	NNP	I-NP	O
,	,	,	O	O
Within	Within	NNP	B-NP	O
Hour	Hour	NNP	I-NP	O
of	of	IN	B-PP	O
Pharmacy	Pharmacy	NNP	B-NP	O
Approval	Approval	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/28/07	7/28/07	CD	B-NP	O
by	by	IN	B-PP	O
ZUWKOWSKI	ZUWKOWSKI	NNP	B-NP	O
,	,	,	O	O
MODESTO	MODESTO	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Connette	Connette	NNP	I-NP	O
3/6/07	3/6/07	CD	I-NP	O
,	,	,	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
am	am	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
7/27/07	7/27/07	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
7	7	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
VLGMHO	VLGMHO	NN	B-NP	O
coumadin	coumadin	NN	I-NP	O
clinic	clinic	NN	I-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
musculoskeletal	musculoskeletal	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
obesity	obesity	NN	I-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Cardiac	Cardiac	NNP	I-NP	O
MIBI	MIBI	NNP	I-NP	O
:	:	:	O	O
preliminary	preliminary	JJ	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
poor	poor	JJ	I-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
small	small	JJ	B-NP	O
reversible	reversible	JJ	I-NP	O
inferior	inferior	JJ	I-NP	O
septal	septal	JJ	I-NP	O
defect	defect	NN	I-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	B-VP	O
likely	likely	RB	I-VP	O
be	be	VB	I-VP	O
artifact	artifact	NN	B-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
cc	cc	NN	B-NP	O
:	:	:	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
hpi	hpi	NN	B-NP	O
:	:	:	O	O
60F	60F	NN	B-NP	O
with	with	IN	B-PP	O
afib	afib	NN	B-NP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
.	.	.	O	O

Woke	Woke	VB	B-VP	O
up	up	RP	B-PRT	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
am	am	NN	I-NP	O
with	with	IN	B-PP	O
L	L	NN	B-NP	O
sided	sided	JJ	I-NP	O
chest	chest	NN	I-NP	O
and	and	CC	O	O
back	back	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Radiation	Radiation	NN	B-NP	O
to	to	TO	B-VP	O
arm	arm	VB	I-VP	O
with	with	IN	B-PP	O
motion	motion	NN	B-NP	O
.	.	.	O	O

+	+	SYM	B-NP	O
nausea	nausea	NN	I-NP	O
,	,	,	O	O
+	+	SYM	B-NP	O
crampy	crampy	JJ	I-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Worse	Worse	JJR	B-ADVP	O
with	with	IN	B-PP	O
arm	arm	NN	B-NP	O
and	and	CC	I-NP	O
body	body	NN	I-NP	O
movement	movement	NN	I-NP	O
.	.	.	O	O

Has	Has	NNP	B-NP	O
1	1	CD	I-NP	O
year	year	NN	I-NP	O
h/o	h/o	NN	I-NP	O
progressive	progressive	JJ	I-NP	O
sob	sob	NN	I-NP	O
with	with	IN	B-PP	O
exertion	exertion	NN	B-NP	O
and	and	CC	O	O
increasing	increase	VBG	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
pmh	pmh	NN	B-NP	O
:	:	:	O	O
htn	htn	NN	B-NP	O
afib	afib	NN	I-NP	O
diagnosed	diagnose	VBD	B-VP	O
2/8	2/8	CD	B-NP	O
echo	echo	JJ	I-NP	O
2/5	2/5	CD	I-NP	O
concentric	concentric	JJ	I-NP	O
LVH	LVH	NN	I-NP	O
.	.	.	O	O

Overall	Overall	RB	B-ADVP	O
left	leave	VBD	B-VP	O
ventricular	ventricular	JJ	B-NP	O
function	function	NN	I-NP	O
is	be	VBZ	B-VP	O
low	low	JJ	B-ADJP	O
normal	normal	JJ	B-ADJP	O
to	to	TO	B-PP	O
mildly	mildly	RB	B-ADJP	O
impaired	impaired	JJ	I-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
estimated	estimate	VBN	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
is	be	VBZ	B-VP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

mild-mod	mild-mod	JJ	B-NP	O
MR	MR	NNP	I-NP	O
Mild	Mild	NNP	I-NP	O
lae	lae	NNP	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
pfo/asd	pfo/asd	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
meds	med	NNS	I-NP	O
:	:	:	O	O
zocor	zocor	NN	B-NP	O
lasix	lasix	NN	I-NP	O
coumadin	coumadin	NN	I-NP	O
toprol	toprol	NN	I-NP	O
asa	asa	NN	I-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
all	all	DT	B-NP	O
:	:	:	O	O
nkda	nkda	NN	B-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
sh	sh	NN	B-NP	O
:	:	:	O	O
remote	remote	VB	B-VP	O
prior	prior	JJ	B-NP	O
h/o	h/o	NN	I-NP	O
smoking	smoking	NN	I-NP	O
,	,	,	O	O
social	social	JJ	B-NP	O
alcohol	alcohol	NN	I-NP	O
no	no	DT	B-NP	O
drugs	drug	NNS	I-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	O	O
physical	physical	JJ	B-ADJP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
:	:	:	O	O
afeb	afeb	NN	B-NP	O
,	,	,	O	O
48	48	CD	B-NP	O
,	,	,	I-NP	O
142/74	142/74	CD	I-NP	O
,	,	,	I-NP	O
99	99	CD	I-NP	O
on	on	IN	B-PP	O
ra	ra	NN	B-NP	O
obese	obese	JJ	I-NP	O
jvp	jvp	NN	I-NP	O
8-10	8-10	CD	I-NP	O
cm	cm	NN	I-NP	O
lungs	lung	NNS	I-NP	O
:	:	:	O	O
cta	cta	NN	B-NP	O
b/l	b/l	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
to	to	TO	B-PP	O
palpation	palpation	NN	B-NP	O
of	of	IN	B-PP	O
anterior	anterior	JJ	B-NP	O
L	L	NN	I-NP	O
chest	chest	NN	I-NP	O
and	and	CC	O	O
posterior	posterior	JJ	B-NP	O
L	L	NN	I-NP	O
scapular	scapular	JJ	B-ADJP	O
and	and	CC	O	O
pain	pain	NN	B-NP	O
in	in	IN	B-PP	O
shoulder	shoulder	NN	B-NP	O
with	with	IN	B-PP	O
movement	movement	NN	B-NP	O
irr	irr	NN	I-NP	O
irr	irr	NN	I-NP	O
2/6	2/6	CD	B-NP	O
sys	sy	NNS	I-NP	O
murmur	murmur	NN	I-NP	O
,	,	,	O	O
feint	feint	JJ	B-NP	O
apical	apical	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
abd	abd	NN	I-NP	O
:	:	:	O	O
benign	benign	JJ	B-NP	O
ext	ext	NN	I-NP	O
:	:	:	O	O
chronic	chronic	JJ	B-NP	O
venous	venous	JJ	I-NP	O
stasis	stasis	NN	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
trace	trace	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
+	+	SYM	I-NP	O
le	le	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
+	+	SYM	B-NP	O
tophi	tophi	NN	I-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
labs	lab	NNS	I-NP	O
:	:	:	O	O
K	K	NN	B-NP	O
3.3	3.3	NN	I-NP	O
,	,	,	O	O
cr	cr	NN	B-NP	O
.9	.9	CD	B-NP	O
studies	study	NNS	I-NP	O
:	:	:	O	O
portable	portable	JJ	B-NP	O
cxr	cxr	NN	I-NP	O
:	:	:	O	O
clear	clear	JJ	B-NP	O
ekg	ekg	NN	I-NP	O
:	:	:	O	O
brady	brady	NN	B-NP	O
at	at	IN	B-PP	O
48	48	CD	B-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
foci	focus	NNS	I-NP	O
,	,	,	O	O
varying	vary	VBG	B-VP	O
pr	pr	NN	B-NP	O
intervals	interval	NNS	I-NP	O
,	,	,	O	O
different	different	JJ	B-NP	O
p	p	NN	I-NP	O
wave	wave	NN	I-NP	O
morphology	morphology	NN	I-NP	O
,	,	,	O	O
q	q	NN	B-NP	O
's	's	POS	B-NP	O
in	in	IN	B-PP	O
III	III	CD	B-NP	O
and	and	CC	O	O
avF	avF	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
change	change	NN	I-NP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
st	st	NN	I-NP	O
changes	change	VBZ	B-VP	O
stress	stress	NN	B-NP	O
test	test	NN	I-NP	O
in	in	IN	B-PP	O
04	04	CD	B-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
ischemia	ischemia	NN	I-NP	O
,	,	,	O	O
4	4	CD	B-NP	O
minutes	minute	NNS	I-NP	O
on	on	IN	B-PP	O
bruce	bruce	NN	B-NP	O
got	get	VBD	B-VP	O
her	her	PRP	B-NP	O
to	to	TO	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
predicted	predict	VBN	B-NP	O
hr	hr	NN	I-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
events	event	NNS	I-NP	O
:	:	:	O	O
6/10	6/10	CD	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
transient	transient	JJ	B-NP	O
LBBB	LBBB	NN	I-NP	B-protein
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
hospital	hospital	NN	B-NP	O
course	course	NN	I-NP	O
:	:	:	O	O
60F	60F	NN	B-NP	O
with	with	IN	B-PP	O
htn	htn	NN	B-NP	O
,	,	,	O	O
afib	afib	NN	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	B-protein
onset	onset	NN	I-NP	I-protein
L	L	NN	I-NP	I-protein
sided	side	VBD	B-VP	I-protein
chest/back/shoulder	chest/back/shoulder	NN	B-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
atypical	atypical	JJ	B-ADJP	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
cp	cp	NN	I-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

ischemia	ischemia	LS	B-LST	O
:	:	:	O	O
It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
likely	likely	RB	B-ADJP	O
musculoskeletal	musculoskeletal	JJ	I-ADJP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
worse	worse	JJR	B-ADJP	O
with	with	IN	B-PP	O
movement	movement	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
arms	arm	NNS	I-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
and	and	CC	I-NP	O
ws	w	NNS	I-NP	O
reproducible	reproducible	JJ	B-ADJP	O
with	with	IN	B-PP	O
palapation	palapation	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
with	with	IN	B-PP	O
serial	serial	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
and	and	CC	I-NP	O
ekgs	ekg	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
continued	continue	VBD	B-VP	O
her	her	PRP	B-NP	O
asa	asa	NN	I-NP	O
,	,	,	O	O
lowered	lower	VBD	B-VP	O
her	her	PRP$	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
bblocker	bblocker	NN	B-NP	O
given	give	VBN	B-VP	O
bradycardia	bradycardia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
started	start	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
ace	ace	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
ETT	ETT	NN	B-NP	O
and	and	CC	O	O
went	go	VBD	B-VP	O
into	into	IN	B-PP	O
rate	rate	NN	B-NP	O
related	related	JJ	I-NP	O
L	L	NN	I-NP	O
bundle	bundle	NN	I-NP	O
branch	branch	NN	I-NP	O
block	block	NN	I-NP	O
.	.	.	O	O

Full	Full	JJ	B-NP	O
report	report	NN	I-NP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Peak	Peak	JJ	B-NP	O
METS	METS	NN	I-NP	O
=	=	SYM	B-VP	O
5.7	5.7	CD	B-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Duke	Duke	JJ	B-NP	O
Treadmill	Treadmill	NN	I-NP	O
Score	Score	NN	I-NP	O
=	=	SYM	B-VP	O
+4	+4	CD	B-NP	O
-LRB-	-LRB-	HYPH	O	O
Moderate	Moderate	JJ	B-NP	O
risk	risk	NN	I-NP	O
:	:	:	O	O
-10	-10	CD	B-NP	O
to	to	TO	I-NP	O
+4	+4	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

HR	HR	NN	B-NP	O
Recovery	Recovery	NN	I-NP	O
=	=	SYM	B-VP	O
29	29	CD	B-NP	O
ASSESSMENT	ASSESSMENT	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Diagnosis	Diagnosis	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
for	for	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
at	at	IN	B-PP	O
HR	HR	NN	B-NP	O
achieved	achieve	VBD	B-VP	O
.	.	.	O	O

Reduced	Reduce	VBN	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
because	because	IN	B-SBAR	O
ECG	ECG	NN	B-NP	O
uninterpretable	uninterpretable	JJ	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
rate	rate	NN	B-NP	O
related	relate	VBN	B-VP	O
LBBB	LBBB	NNP	B-NP	B-protein
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Prognosis	Prognosis	NN	B-NP	O
:	:	:	O	O
Elevated	Elevated	JJ	B-NP	O
prognostic	prognostic	JJ	I-NP	O
risk	risk	NN	I-NP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
low	low	JJ	B-NP	O
functional	functional	JJ	I-NP	O
capacity	capacity	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
Duke	Duke	NNP	I-NP	O
score	score	NN	I-NP	O
of	of	IN	B-PP	O
+4	+4	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
Moderate	Moderate	NNP	I-NP	O
risk	risk	NN	I-NP	O
:	:	:	O	O
-10	-10	CD	B-NP	O
to	to	TO	I-NP	O
+4	+4	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Arrhythmia	Arrhythmia	NN	B-NP	O
:	:	:	O	O
Probable	Probable	JJ	B-NP	O
rate	rate	NN	I-NP	O
related	related	JJ	I-NP	O
LBBB	LBBB	NN	I-NP	B-protein
at	at	IN	B-PP	O
peak	peak	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Hemodynamics	Hemodynamic	NNS	B-NP	O
:	:	:	O	O
Normal	Normal	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
hemodynamics	hemodynamic	NNS	I-NP	O
.	.	.	O	O

Cardiology	Cardiology	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
they	they	PRP	B-NP	O
recommended	recommend	VBD	B-VP	O
a	a	DT	B-NP	O
MIBI	MIBI	NNP	I-NP	O
and	and	CC	O	O
echo	echo	VB	B-VP	O
to	to	TO	I-VP	O
better	well	RBR	I-VP	O
evaluate	evaluate	VB	I-VP	O
her	her	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
then	then	RB	B-ADVP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
MIBI	MIBI	NN	I-NP	B-protein
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
inferior	inferior	JJ	I-NP	O
septaldefect	septaldefect	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
likely	likely	RB	I-VP	O
be	be	VB	I-VP	O
artifact	artifact	NN	B-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
small	small	JJ	I-NP	O
area	area	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
medical	medical	JJ	B-NP	O
management	management	NN	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
best	good	JJS	I-NP	O
approach	approach	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
small	small	JJ	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
bblocker	bblocker	NN	B-NP	O
,	,	,	O	O
ace	ace	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
asa	asa	NN	I-NP	O
and	and	CC	I-NP	O
statin	statin	NN	I-NP	O
.	.	.	O	O

Pump	Pump	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
lasix	lasix	NN	I-NP	O
had	have	VBD	B-VP	O
recently	recently	RB	I-VP	O
been	be	VBN	I-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
bid	bid	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
volume	volume	NN	B-NP	O
overloaded	overload	VBN	B-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
dose	dose	NN	I-NP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
echo	echo	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
and	and	CC	O	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
ran	run	VBD	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
side	side	NN	I-NP	O
so	so	IN	B-SBAR	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
lower	low	JJR	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
bblocker	bblocker	NN	I-NP	O
.	.	.	O	O

rhythm	rhythm	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
has	have	VBZ	B-VP	O
underlying	underlie	VBG	I-VP	O
conduction	conduction	NN	B-NP	O
system	system	NN	I-NP	O
disease	disease	NN	I-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
degree	degree	NN	I-NP	O
av	av	NN	I-NP	O
block	block	NN	I-NP	O
and	and	CC	O	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
bundle	bundle	NN	I-NP	O
branch	branch	NN	I-NP	O
block	block	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
HR	HR	NN	I-NP	O
of	of	IN	B-PP	O
150	150	CD	B-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
ETT	ETT	NN	I-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
for	for	IN	B-PP	O
h/o	h/o	NN	B-NP	B-protein
afib	afib	JJ	I-NP	I-protein
musculoskeletal	musculoskeletal	JJ	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
:	:	:	O	O
pain	pain	NN	B-NP	O
improved	improve	VBD	B-VP	O
with	with	IN	B-PP	O
standing	stand	VBG	B-VP	O
tylenol	tylenol	NN	B-NP	O
and	and	CC	I-NP	O
motrin	motrin	NN	I-NP	O
standing	standing	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
oxycodone	oxycodone	NN	B-NP	O
for	for	IN	B-PP	O
breakthrough	breakthrough	NN	B-NP	O
endocrine	endocrine	NN	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
fasting	fasting	NN	I-NP	O
glucoses	glucose	NNS	I-NP	O
showed	show	VBD	B-VP	O
borderline	borderline	JJ	B-NP	O
glucose	glucose	NN	I-NP	O
intolerance	intolerance	NN	I-NP	O
with	with	IN	B-PP	O
values	value	NNS	B-NP	O
around	around	IN	B-PP	O
110	110	CD	B-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

fen	fen	NN	B-NP	O
:	:	:	O	O
low	low	JJ	B-NP	O
fat	fat	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
salt	salt	NN	I-NP	O
diet	diet	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
you	you	PRP	B-NP	O
primary	primary	JJ	B-NP	O
care	care	NN	I-NP	O
provider	provider	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
significant	significant	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
call	call	VB	I-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
if	if	IN	B-SBAR	O
your	your	PRP$	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
worsens	worsen	NNS	I-NP	O
,	,	,	O	O
you	you	PRP	B-NP	O
develop	develop	VBP	B-VP	O
new	new	JJ	B-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
you	you	PRP	B-NP	O
feel	feel	VBP	B-VP	O
lightheaded	lightheade	VBN	B-ADJP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
started	start	VBN	I-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
medicine	medicine	NN	I-NP	O
for	for	IN	B-PP	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	O	O
have	have	VBP	B-VP	O
lowered	lower	VBN	I-VP	O
the	the	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
other	other	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
medicine	medicine	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
f/u	f/u	NN	B-NP	O
final	final	JJ	I-NP	O
MIBI	MIBI	NN	I-NP	O
results	result	NNS	I-NP	O
f/u	f/u	VBP	B-VP	O
final	final	JJ	B-NP	O
echo	echo	JJ	I-NP	O
results	result	NNS	I-NP	O
f/u	f/u	VBP	B-VP	O
electrolytes	electrolyte	NNS	B-NP	O
on	on	IN	B-PP	O
ace-inhibitor	ace-inhibitor	NN	B-NP	O
consider	consider	NN	I-NP	O
PFTs	PFT	NNS	I-NP	O
to	to	TO	B-VP	O
better	well	RBR	I-VP	O
evaluate	evaluate	VB	I-VP	O
reason	reason	NN	B-NP	O
for	for	IN	B-PP	O
progressive	progressive	JJ	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
appear	appear	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
cardiac	cardiac	JJ	B-ADJP	O
in	in	IN	B-PP	O
cause	cause	NN	B-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
titrate	titrate	NN	I-NP	O
bblocker	bblocker	NN	I-NP	O
and	and	CC	I-NP	O
ace-inhibitor	ace-inhibitor	NN	I-NP	O
follow	follow	VBP	B-VP	O
fasting	fast	VBG	I-VP	O
glucose	glucose	NN	B-NP	O
values	value	NNS	I-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
KORNBLATT	KORNBLATT	NNP	B-NP	O
,	,	,	O	O
RICKEY	RICKEY	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
XX759	XX759	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
6/6/07	6/6/07	CD	I-NP	O
@	@	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
16	16	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

